GLP-3® is a proprietary Retatrutide blend. Retatrutide is a GGG tri-agonist that targets GLP-1, GIP, and glucagon receptors, offering a comprehensive approach to metabolic regulation. By activating all three receptors, it promotes delayed gastric emptying and appetite control through GLP-1 and GIP pathways, while the unique glucagon receptor activation enhances the breakdown of stored fats and glycogen, increasing basal metabolism for more consistent fat loss. This multi-receptor approach distinguishes GLP-3® from traditional single-agonist GLP-1 therapies.
Our peptides are intended solely for scientific research and development purposes. For wholesale or practitioner pricing, please contact us.
